Officals warn of rise in fake 'Made in Korea' labels
Last year, South Korea imported more Chinese apparel than ever before. According to the Korea Customs Service, the country brought in $4.83 billion worth of clothing from China, up 50 percent from 2020.
With the rise in volume, the authorities are seeing a surge in a deceptive practice known in Korea as "label switching." Imported garments arrive with tags that say "Made in China," but these are often swapped out before reaching the customer. Korean sellers repackage the items to appear as if they were produced in South Korea.
In some cases, they even change the shipping invoices and boxes.
Korean customs officials report that in the first half of 2025, they seized 3.1 million illegally distributed goods. More than half (1.7 million) were flagged for missing or false country-of-origin labels. Most of these were Chinese clothes disguised as Korean products.
Korean sellers often buy these clothes for under $2 on platforms like Temu or AliExpress, then resell them on other e-commerce platforms or social media at 10 times the price. Many are advertised with vague claims like "luxury local fabric."
This comes as Chinese fast-fashion giant Shein sees a sharp rise in sales here. According to Mobile Index, a data service operated by South Korea-based IGAWorks, Shein's monthly active users in the country hit 1.75 million in June. This is almost four times higher than in January.
It now ranks sixth among fashion shopping apps in Korea, up from 11th last year. Another analytics firm, WiseApp Retail, reports that Shein passed 2.2 million Korean users for the first time, the highest ever recorded.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
4 hours ago
- Korea Herald
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology
BELLEVUE, Wash. and SEOUL, South Korea, July 24, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced it has signed a term sheet ("Term Sheet") with Woori IO Co., Ltd. ("WORIO"), a South Korean medical device company developing next-generation noninvasive glucose monitoring technology. The agreement sets forth certain key terms for a strategic acquisition of WORIO by OSR Holdings' Korean affiliate, OSR Holdings Co., Ltd. ("OSRK"). Under the proposed structure, WORIO will become a wholly owned subsidiary of OSRK. Shareholders of WORIO will receive newly issued shares of OSRK through the share exchange and may be eligible to convert them into OSRH common stock traded on NASDAQ, subject to certain conditions including "$10 per OSRH share" condition. Specifically, WORIO shareholders may convert their OSRK shares into OSRH shares at a fixed exchange ratio of 1 OSRK share = 12.96 OSRH shares, provided that OSRH's stock price reaches $10.00 at least once within three years following the signing of the Term Sheet. If this condition is not met, the parties have agreed to renegotiate in good faith. The agreement includes a 6-month exclusivity period, during which OSRK will conduct confirmatory legal and financial due diligence with a target to complete this transaction within this exclusivity period. WORIO's proprietary platform uses near-infrared spectroscopy (NIRS) to measure glucose without needles, sensors, or skin penetration — representing a truly noninvasive alternative to today's continuous glucose monitors (CGMs). Its solution aims to eliminate the burden of pain and daily finger pricks for millions of people with diabetes. According to recent global market research, the blood glucose monitoring devices market is expected to exceed $40 billion by 2030, growing at a CAGR of 8–10%, driven by rising diabetes prevalence and the convergence of medical technology with consumer electronics. Demand for noninvasive and wearable monitoring systems is expected to be a major growth driver. Dexcom, one of the market leaders in minimally invasive CGM which is the current standard of care has more than $32 billion in market capitalization (as of July 11), underscoring the significant commercial potential of advanced glucose monitoring solutions. Noninvasive alternatives hold tremendous promise and are poised to become an integral part of diabetes management in the future. WORIO has completed a proof-of-concept study with the Korea University Hospital (Guro) to validate the accuracy and effectiveness of its prototype devices and the data measured by them, based on which the company plans to enter a larger confirmatory trial to be registered with the Ministry of Food and Drug Safety (MFDS) of Korea for medical device approval pathway. WORIO's noninvasive technology is well positioned to be integrated into wearable glucose monitoring devices such as smart watches — WORIO has been selected by Samsung Electronics' innovative startup program ("C-Lab Outside") in Q1 2025. "We believe this initial milestone with Woori IO aligns strongly with our mission to accelerate breakthrough healthcare innovations with global impact," said Peter Hwang, CEO of OSRH. "Woori IO's breakthrough noninvasive glucose monitoring platform, coupled with its high-profile partnership with global companies, puts OSRH in a position to become a first mover in this fast-growing global market." Following the signing of this Term Sheet, both parties will proceed with due diligence and aim to execute definitive agreements within the 6 months exclusivity period. About OSR Holdings, Inc. OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno-oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting-edge research and development. For more information, visit About Woori IO Co., Ltd. Woori IO is a medical device company based in Jeonju, South Korea, focused on the development of noninvasive biosensing solutions. Its proprietary NIRS-based glucose monitoring system enables accurate, pain-free, and user-friendly diabetes management, with strong potential for wearable integration. For more information, visit
Korea Herald
6 hours ago
- Korea Herald
Lee's top security aide meets US officials ahead of tariff deadline
National Security Adviser Wi Sung-lac said Thursday he has met with senior officials of the Donald Trump administration during his recent visit to the United States to support ongoing trade negotiations as the tariff deadline looms. In a press notice, Wi said he accompanied Trade Minister Yeo Han-koo for talks with US Secretary of Commerce Howard Lutnick and US Trade Representative Jamieson Greer during his stay in Washington earlier this week. He also held a phone consultation with US Secretary of State Marco Rubio and met with Under Secretary of State for Political Affairs Allison Hooker during the visit. "The visit to the US was part of a broader strategic dialogue encompassing both security and economic issues between South Korea and the US, with the aim of supporting follow-up discussions on specific economic matters," Wi said in the notice, without elaborating. His second trip to Washington this month comes at a critical time, as Seoul faces mounting pressure to strike a deal with the US to stave off the imposition of 25 percent tariffs on Korean exports before the Aug. 1 deadline, through a comprehensive trade and investment package. The finance and trade chiefs of the two countries had been scheduled to hold "2+2" high-level talks in Washington on Friday. But Seoul announced earlier in the day that the meeting was postponed due to US Treasury Secretary Scott Bessent's urgent schedule.
Korea Herald
10 hours ago
- Korea Herald
Kospi ends higher amid postponed tariff talks; won sharply up
Seoul shares closed slightly higher Thursday amid heightened concerns over high-level trade talks between South Korea and the United States. The Korean won rose sharply against the US dollar. The benchmark Korea Composite Stock Price Index added 6.68 points, or 0.21 percent, to close at 3,190.45. The index had surpassed the 3,230-point mark during the morning session, but trimmed earlier gains on news the "2+2" high-level trade talks between Seoul and Washington, originally planned for Friday (US time) in Washington, were postponed due to the urgent schedule of US Treasury Secretary Scott Bessent. The two sides had planned to hold the high-stake negotiations involving Bessent, US Trade Representative Jamieson Greer and their respective Korean counterparts -- Finance Minister Koo Yun-cheol and Trade Minister Yeo Han-koo. "News like this ahead of the planned imposition of 25 percent reciprocal tariffs on Aug. 1 raises concerns for investors," Seo Sang-young, an analyst at Mirae Asset Securities, said. "After the news, major Korean automobile firms trimmed their earlier gains or turned to losses," he added. Trade volume was moderate at 422.4 million shares worth 12.9 trillion won ($9.4 billion), with losers outnumbering winners 707 to 192. Foreigners and institutions purchased local shares worth 736.7 billion won and 128.8 billion won, respectively, while retail investors dumped 950.9 billion won. Battery and shipbuilding shares were particularly strong in Thursday's session. Leading battery maker LG Energy Solution shot up 9.36 percent to 368,000 won and its smaller rival Samsung SDI advanced 3.09 percent to 190,300 won. Major shipbuilder HD Hyundai Heavy rose 1.69 percent to 420,000 won and Hanwha Ocean jumped 6.35 percent to 88,800 won. Defense giant Hanwha Aerospace also soared 3.41 percent to 941,000 won, while biopharmaceutical powerhouse Samsung Biologics climbed 2.26 percent to 1.09 million won. Major power equipment builder Doosan Enerbility also surged 3.15 percent to 65,400 won. Korean chipmaking giant SK hynix rose 0.19 percent to 269,500 won after the company reported record high operating profit and sales for the April-June period, while its rival Samsung Electronics lost 0.6 percent to 66,000 won. Top automaker Hyundai Motor, meanwhile slid 2.03 percent to 217,500 won with a sharp drop in operating profit in the second quarter partially due to the effects of 25 percent auto tariffs by the Trump administration. Its sister, Kia, also went down 1.04 percent to 105,000 won. IT shares also lost ground. Naver, the operator of Korea's largest internet portal, dipped 1.94 percent to 227,000 won and Kakao, the operator of the country's dominant mobile messenger, shed 1.64 percent to 54,100 won. The local currency was quoted at 1,367.2 won against the US dollar at 3:30 p.m., sharply up 12.6 won from the previous session. (Yonhap)
